Zygolide® (pergolide tablets)

Zygolide® is indicated for the control of clinical signs associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing's Disease) in horses.
 
Zygolide® should be administered orally at a starting dose of 2 mcg/kg once daily. Dosage may be adjusted to effect, not to exceed 4 mcg/kg daily. 
 
Pack size(s): 60ct, 160 ct
Documents: Package insert get_app SDS get_app

Important safety information

As with all drugs, side effects may occur. Zygolide® (pergolide tablets) is for use in horses only. Zygolide® has not been evaluated in breeding, pregnant or lactating horses. Treatment with Zygolide® may cause loss of appetite. Most cases are mild. If severe, a temporary dose reduction may be necessary. Weight loss, lack of energy, and behavioral changes also may be observed. Zygolide® tablets should not be crushed due to the potential for increased human exposure. Pregnant or lactating women should wear gloves when administering this product. Zygolide® is contraindicated in horses with hypersensitivity to pergolide mesylate or other ergot derivatives. Keep Zygolide® in a secure location out of reach of dogs, cats, and other animals to prevent accidental ingestion or overdose. Dogs have eaten Zygolide® tablets that were placed in food intended for horses or dropped during administration of the tablets to the horses. Adverse reactions may occur if animals other than horses ingest Zygolide® tablets. Refer to the prescribing information for complete details or visit www.dechra‐ us.com.

 

Got More Questions?

keyboard_arrow_up